BlackRock Investment Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

BlackRock Investment Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$455K	Hold	48,674	–	–	﹤0.01%	3072
2016 Q3	$476K	Sell	48,674 -80	-0.2%	-$1.08K	﹤0.01%	3071
2016 Q2	$689K	Buy	48,754 +18,034	+59%	+$281K	﹤0.01%	2876
2016 Q1	$429K	Buy	30,720 +1,009	+3%	+$14.8K	﹤0.01%	2951
2015 Q4	$606K	Buy	29,711 +55	+0.2%	+$848	﹤0.01%	2919
2015 Q3	$390K	Sell	29,656 -386	-1%	-$6.4K	﹤0.01%	3107
2015 Q2	$461K	Buy	30,042 +13,366	+80%	+$256K	﹤0.01%	3148
2015 Q1	$333K	Buy	16,676 +262	+2%	+$5.86K	﹤0.01%	3107
2014 Q4	$345K	Buy	16,414 +110	+0.7%	+$2.24K	﹤0.01%	3151
2014 Q3	$303K	Buy	16,304 +2,512	+18%	+$45.5K	﹤0.01%	3171
2014 Q2	$319K	Buy	+13,792	New	+$243K	﹤0.01%	3181

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BlackRock Investment Management's AGTC Position: Q4 2016 in Review

BlackRock Investment Management held its Applied Genetic Technologies Corporation (AGTC) position steady in Q4 2016 at 48,674 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

BlackRock Investment Management first reported a position in AGTC in Q2 2014 and has held it in 11 quarters since. The position peaked at $689K in Q2 2016. 90 funds tracked by Wall St. Rank hold AGTC as of Q4 2016.

BlackRock Investment Management held 48,674 shares of Applied Genetic Technologies Corporation worth $455K as of Q4 2016.
BlackRock Investment Management left its Applied Genetic Technologies Corporation share count unchanged in Q4 2016.
Applied Genetic Technologies Corporation made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3072 holding.
BlackRock Investment Management first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Applied Genetic Technologies Corporation position peaked at $689K in Q2 2016.
90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.